Patients with melanoma metastases at cutaneous and subcutaneous sites are highly susceptible to interleukin-2-based therapy.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/F421C04F.svg?ark=w1%2F20260515%2FF421C04F&value=id)](https://nobleid.org/work/w1/20260515/F421C04F)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors